Chipeta, J <br/><br/>
Neonatal (cord blood) T cells can competently raise type 1 and 2 immune responses upon polyclonal activation.  [electronic resource] 

 -  Cellular immunology  Nov 2000 
 - 110-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-8749 
<br/><br/><label>Standard No.: </label>10.1006/cimm.2000.1718  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cells, Cultured<br/>Fetal Blood--cytology<br/>Humans<br/>Interferon-gamma--biosynthesis<br/>Interleukin-10--biosynthesis<br/>Interleukin-12--biosynthesis<br/>Interleukin-2--biosynthesis<br/>Interleukin-4--biosynthesis<br/>Leukocyte Common Antigens--immunology<br/>Leukocytes, Mononuclear--drug effects<br/>Lymphocyte Activation--drug effects<br/>Muromonab-CD3--administration & dosage<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 1<br/>Receptors, Interleukin-2--biosynthesis<br/>T-Lymphocytes, Cytotoxic--cytology<br/>Th1 Cells--cytology<br/>Th2 Cells--cytology<br/>Tumor Necrosis Factor-alpha--biosynthesis